Site advantages
Excellent research, maximum and specialized health care, a knowledge-based economy and multifaceted education and training in the healthcare industry are distinguishing features of Buch. With its clear focus on biomedicine, the health location has outstanding innovation and growth potential. Berlin-Buch has been designated as a premier location for future development in the innovation strategy of the capital city region.
There basic and clinical researchers from academia and non-university institutions are closely interlinked, as are the hospitals, and biotech companies and medical technology companies. Altogether, as key employers in Berlin-Buch, they employ nearly 6,500 people in the health sector. In addition, the health location Berlin-Buch generates an annual value of 320 million euros plus an additional 227 million euros in demand effects in Berlin. As a consequence, over 7,500 jobs have been created in Berlin, resulting in tax revenues for Berlin of 13 million euros per year *.
Thanks to the public funding by the Federal Government and the State of Berlin amounting to 700 million euros*, the research campus in Berlin-Buch has an excellent scientific infrastructure, state-of-the art technology platforms and a biotech park with around 75 companies. The renown of the science and health location attracts world-class scientists and is a magnet for new companies and enterprises.
This has meant that in recent years substantial private investments of 827 million euros have been invested in the region**. The HELIOS Kliniken group has established a maximum-care hospital in Buch and has invested 336 million euros** for this purpose. Thanks to the commitment of companies such as UKB Denkmal AG, COMBAG AG, Ludwig Hoffmann Quartier Objektgesellschaft mbH & Co. KG and the Widerker Group, historic hospital properties have been converted into attractive residential parks. Moreover, a shopping mall, the Schlosspark-Passage has been built in the center of Buch. Companies of the BiotechPark have attracted private investments, including hundreds of millions of euros in venture capital.
Significant economic effects for Berlin through planned investments at the future location Berlin-Buch
Investments of 729 million euros are planned for the healthcare location by 2035, primarily in the structural expansion of the science and biotech campus. This could create 3,800 additional jobs at the Buch site, including 1,275 jobs in biotechnology and medical technology. The gross domestic product could increase by 1.44 billion euros as a result of these investments, and Berlin could generate additional public revenue of around 125 million euros.***
*Up to and including 2024
**Up to and including 2018
***Source: Study by Investionsbank Berlin “Berlin aktuell - Wirtschaftliche Impulse des Zukunftsortes Berlin-Buch”
Nine good reasons for settling on Campus Berlin-Buch
- Premier capital city location
- Immediate availability of space
- Specialized labor force
- Excellent research centers and hospitals on the campus
- Attractive rental terms
- Staff development and in-service training on-site
- Vibrant and cosmopolitan Campus community
- Interdisciplinary networks and platforms with uncomplicated access
- Increasing attractiveness of Berlin-Buch as place to live for Campus employees
News Buch Berlin
Alithea Bio Scores Double Victory at VivaTech 2026 for Breakthrough in Preclinical Safety
Deep-tech biotech innovator Alithea Bio has achieved a spectacular double victory at VivaTech 2026, Europe’s largest startup and tech event, taking home both the coveted “Tech for Change” Jury Prize a...
more ...Eckert & Ziegler SE Annual General Meeting Approves Significantly Higher Dividend
The Annual General Meeting of Eckert & Ziegler SE (ISIN DE0005659700) today approved the proposal of the Executive Board and Supervisory Board and resolved to pay a dividend of € 0.22 per share (previ...
more ...ERC Advanced Grants awarded to two Berlin researchers
Uwe Ohler and Gaetano Gargiulo have been awarded prestigious ERC Advanced Grants. With funding of €2.5 million each, they will spend the next five years investigating how protein synthesis is regulate...
more ...Events Buch Berlin
27.08.2026, 10:00
CRISPR/Cas: Grundlagen und praktische Anwendung (Verschoben vom 4. Juni auf 27. August)
Der Crashkurs für Einsteiger*innen vermittelt die Grundlagen der CRISPR/Cas Technologie. Die Teilnehmer*innen sollen in die Lage versetzt werden, CRISPR/Cas Experimente selbständig zu planen und durch...
more ...22.09.2026, 09:00
GMP Biotech Summer School
Knowing and applying the Good Manufacturing Practice (GMP) regulations is one of the key elements in the manufacture of medicinal products for clinical trials and on an industrial level.
more ...09.11.2026, 09:00
Fachkraft für Molekularbiologie
Elftägiges Intensivseminar der Berlin BioScience Academy. Es rmittelt Grundlagenwissen zu den wichtigsten Labormethoden der modernen Molekularbiologie und vermittelt Einblicke in die klinische Forschu...
more ...